Future Of British Business
Abcam Founder Pushes for Better Performance at Biotech
- UK entrepreneur Milner seeks board seat at $4 billion firm
- Scientist aims to shape direction at ‘Amazon of antibodies’
This article is for subscribers only.
Abcam Plc founder Jonathan Milner is pushing for better performance at the biotechnology supplier he started 25 years ago.
The British scientist and entrepreneur aims to take a more active role in influencing Abcam’s governance, performance and direction, according to a filing Monday, which confirmed an earlier Bloomberg News report.